news
FDA Advisory Committee recommends KYNAMRO™ for homozygous familial hypercholesterolemia
18 October 2012 | By Sanofi
"We are very encouraged by the support for KYNAMRO..."
List view / Grid view
Sanofi
news
Genzyme presents second Phase III study of once-daily oral AUBAGIO® (teriflunomide) confirming significant impact on disability
12 October 2012 | By Sanofi
Sanofi and Genzyme announced that key data from the TOWER trial were presented at the 28th Congress of the ECTRIMS...
news
Sanofi to launch state-of-the art, reusable insulin pen AllStar™ in India
9 October 2012 | By Sanofi
Sanofi announced the launch by Sanofi India Limited of AllStar™...
news
Genzyme to present new data from AUBAGIO® and LEMTRADA(TM) Clinical Development Programs at ECTRIMS
9 October 2012 | By Genzyme
New data from Genzyme’s clinical development programs...
news
Journal of Clinical Oncology publishes Phase III results of ZALTRAP® (aflibercept) VELOUR study
Sanofi (EURONEXT: SAN and NYSE: SNY) today announced that detailed results from the pivotal Phase III VELOUR study evaluating ZALTRAP® (aflibercept) Injection for Intravenous Infusion for the treatment of patients with previously treated metastatic colorectal cancer were published in the October 2012 edition of the Journal of Clinical Oncology (JCO).
news
New data from ORIGIN
5 October 2012 | By Sanofi
New data from ORIGIN shows Lantus® use is about 3 times more likely to achieve and sustain target HbA1c vs. standard care over 5 years in the study population...
news
Sanofi and Bristol-Myers Squibb announce restructuring of alliance agreement
3 October 2012 | By Bristol-Myers Squibb Company
Sanofi & Bristol-Myers Squibb have restructured their long-term alliance...
news
Sanofi appoints Dr. Paul Chew, Chief Medical Officer and Head of Global Medical Affairs
1 October 2012 | By Sanofi
Sanofi is pleased to announce the appointment of Dr. Paul Chew...
news
Sanofi and TB Alliance announce collaboration to accelerate new treatments against tuberculosis
20 September 2012 | By Sanofi
Sanofi and TB Alliance have announced a new research collaboration agreement...
news
Ten pharmaceutical companies unite to accelerate development of new medicines
19 September 2012 | By Bristol-Myers Squibb
New non-profit organization to speed pharmaceutical R&D...
news
FDA approves Genzyme’s AUBAGIO®
12 September 2012 | By Sanofi
AUBAGIO® (teriflunomide), a once-daily, oral treatment for relapsing Multiple Sclerosis...
news
Sanofi announces FDA approval for Auvi-Q™
13 August 2012 | By Sanofi
Breakthrough device design talks patients and caregivers through the injection process...
news
Sanofi and Regeneron launch comprehensive Phase 3 clinical program with LDL cholesterol-lowering PCSK9 antibody
20 July 2012 | By Sanofi
ODYSSEY will comprise over 10 clinical trials...
news
Sanofi announces 2012 Patient Group Bursary winners
18 July 2012 | By Sanofi
Ataxia UK, Crohn’s & Colitis UK & Muscular Dystrophy Campaign share £50,000 to help better the lives of patients throughout the UK...
news
Seven pharmaceutical companies join academic researchers to speed TB drug discovery
6 July 2012 | By Abbott
Groundbreaking partnership that aims to speed the discovery of essential new treatments...
